
1867: Transmission Window
FDA Leadership Turmoil and Medical Reviewer Departures
The FDA is reportedly facing significant internal upheaval, with a loss of nearly half of its medical reviewers in key divisions like oncology and hematology. Dr. Scott Gottlieb noted that the departure of career experts and the influx of political appointees are damaging the agency's ability to regulate 20% of the US economy effectively.















